Added to YB: 2025-08-25
Pitch date: 2025-08-21
PBH [neutral]
Prestige Consumer Healthcare Inc.
-7.09%
current return
Author Info
A Peek Behind the Numbers is uncovering earnings manipulation and one-time benefits that Wall Street seldom talks about. Sign up for the newsletter.
Company Info
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
Market Cap
$2.8B
Pitch Price
$66.13
Price Target
N/A
Dividend
N/A
EV/EBITDA
9.08
P/E
14.59
EV/Sales
3.38
Sector
Pharmaceuticals
Category
turnaround
Prestige Consumer Healthcare’s (PBH) Q1’26 Miss- A Familiar Story
PBH (earnings update): Q1'26 missed revenue/EPS, guidance slashed from 1-2% growth to -1.5-3% decline. Mgmt blames Clear Eyes supply issues & macro, but knew comp was tough. Goodwill/intangibles = 82% of assets vs $3.6B market cap, increasing impairment risk. Short-term levers: cut marketing (3c EPS boost), high accrued marketing, drawing down bad debt reserve (3.5c EPS boost).
Read full article (2 min)